Abstract

Uveitis is characterised by breakdown of the blood-retinal barrier (BRB), allowing infiltration of immune cells that mediate intraocular inflammation, which can lead to irreversible damage of the neuroretina and the loss of sight. Treatment of uveitis relies heavily on corticosteroids and systemic immunosuppression due to limited understanding of disease pathogenesis. We performed single-cell RNA-sequencing of retinas, as well as bulk RNA-sequencing of retinal pigment epithelial (RPE) cells from mice with experimental autoimmune uveitis (EAU) versus healthy control. This revealed that the Th1/Th17-driven disease induced strong gene expression changes in response to inflammation in rods, cones, Müller glia and RPE. In particular, Müller glia and RPE cells were found to upregulate expression of chemokines, complement factors, leukocyte adhesion molecules and MHC class II, thus highlighting their contributions to immune cell recruitment and antigen presentation at the inner and outer BRB, respectively. Additionally, ligand-receptor interaction analysis with CellPhoneDB revealed key interactions between Müller glia and T cell / natural killer cell subsets via chemokines, galectin-9 to P4HB/TIM-3, PD-L1 to PD-1, and nectin-2/3 to TIGIT signalling axes. Our findings elucidate mechanisms contributing to breakdown of retinal immune privilege during uveitis and identify novel targets for therapeutic interventions.

Details

Title
Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis
Author
Quinn, Joel 1 ; Salman, Ahmed 1 ; Paluch, Christopher 2 ; Jackson-Wood, Matthew 3 ; McClements, Michelle E. 1   VIAFID ORCID Logo  ; Luo, Jian 4 ; Davis, Simon J. 5 ; Cornall, Richard J. 6 ; MacLaren, Robert E. 7   VIAFID ORCID Logo  ; Dendrou, Calliope A. 8 ; Xue, Kanmin 9   VIAFID ORCID Logo 

 University of Oxford, Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 MiroBio Ltd, Oxford, UK (GRID:grid.4991.5); John Radcliffe Hospital, University of Oxford, Radcliffe Department of Medicine, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492); John Radcliffe Hospital, University of Oxford, Medical Research Council Human Immunology Unit, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492) 
 MiroBio Ltd, Oxford, UK (GRID:grid.8348.7) 
 University of Oxford, Respiratory Medicine Unit, Nuffield Department of Medicine, Experimental Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 John Radcliffe Hospital, University of Oxford, Radcliffe Department of Medicine, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492); John Radcliffe Hospital, University of Oxford, Medical Research Council Human Immunology Unit, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492) 
 University of Oxford, Nuffield Department of Medicine, Henry Wellcome Building for Molecular Physiology, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); CAMS Oxford Institute, University of Oxford, Henry Wellcome Building for Molecular Physiology, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 University of Oxford, Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492) 
 University of Oxford, Nuffield Department of Medicine, Wellcome Centre for Human Genetics, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Kennedy Institute of Rheumatology, University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 University of Oxford, Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492); John Radcliffe Hospital, Nuffield Department of Clinical Neurosciences, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492) 
Pages
20033
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3098041450
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.